Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Carrier screening panels for Ashkenazi Jews: Is more better?

1 Mar 2005

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Genomics and Rare Diseases
Glycogen Storage Diseases and Myoclonus
Lysosomal Storage Disorders Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 15775754
DOI: 10.1097/01.gim.0000156527.87525.8f

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Carrier screening panels for Ashkenazi Jews: Is more better?PMID 15775754Read ↗

Genetic diseases and testing in Ashkenazi Jews: Part 1.Semantic proximity Read ↗

DNA-based carrier screening in the Ashkenazi Jewish population.Semantic proximity Read ↗

Results of the College of American Pathology/American College of Medical Genetics and Genomics external proficiency testing from 2006 to 2013 for three conditions prevalent in the Ashkenazi Jewish populationSemantic proximity Read ↗

Establishing criteria for a carrier detection panel: lessons from the Ashkenazi Jewish model.Semantic proximity Read ↗

Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory.Semantic proximity Read ↗

Expanded carrier screening panels—does bigger mean better?Semantic proximity Read ↗

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.Semantic proximity Read ↗

Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: a call for evidence.Semantic proximity Read ↗

Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic mazeSemantic proximity Read ↗

Lessons learned from expanded reproductive carrier screening in self‐reported Ashkenazi, Sephardi, and Mizrahi Jewish patientsSemantic proximity Read ↗

Carrier screening for genetic disorders in individuals of Ashkenazi Jewish descent.Semantic proximity Read ↗

ACOG Committee Opinion No. 442: Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish DescentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.